Therapeutic evaluation of microRNA-15a and microRNA-16 in ovarian cancer
Treatment of chemo-resistant ovarian cancer (OvCa) remains clinically challenging and there is a pressing need to identify novel therapeutic strategies. Here we report that multiple mechanisms that promote OvCa progression and chemo-resistance could be inhibited by ectopic expression of miR-15a and...
Main Authors: | Dhar Dwivedi, Shailendra Kumar, Mustafi, Soumyajit Banerjee, Mangala, Lingegowda S., Jiang, Dahai, Pradeep, Sunila, Rodriguez-Aguayo, Cristian, Ling, Hui, Ivan, Cristina, Mukherjee, Priyabrata, Calin, George A., Lopez-Berestein, Gabriel, Sood, Anil K., Bhattacharya, Resham |
---|---|
Format: | Online |
Language: | English |
Published: |
Impact Journals LLC
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924772/ |
Similar Items
-
microRNA Therapeutics in Cancer — An Emerging Concept
by: Shah, Maitri Y., et al.
Published: (2016) -
Circulating microRNA, secreted microRNA and exogenous plant microRNA
by: Zhang, Chenyu
Published: (2012) -
MicroRNA therapeutics: principles, expectations, and challenges
by: Rupaimoole, Rajesha, et al.
Published: (2011) -
Hypoxia-upregulated microRNA-630 targets Dicer, leading to increased tumor progression
by: Rupaimoole, Rajesha, et al.
Published: (2016) -
MicroRNA Processing and Human Cancer
by: Ohtsuka, Masahisa, et al.
Published: (2015)